Alpha Tau Medical Ltd (DRTSW) News

Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

The pooled analysis included data from 4 international clinical trials spanning an array of hard-to-treat...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alpha Tau to Present at the Jefferies Global Healthcare Conference

JERUSALEM, May 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ:...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update

- Presented preclinical data demonstrating abscopal immune effect in pancreatic murine tumor models at ESTRO...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer

JERUSALEM, May 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ:...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow

- Initial data demonstrates significant reduction in distant pancreatic cancer tumor growth rate starting from...

Alpha Tau to Participate in May Investor Conferences

JERUSALEM, May 01, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ:...

Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit

JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ:...

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

- Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs of...

Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference

JERUSALEM, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ:...

Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference

- The overview presentation will review some of the Company’s recent achievements, including highly promising...